Boston Scientific Corp. (BSX)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$0.64 (-0.72%)Past Day

About

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.

Key Insights

  • Share Price

    $85.33

  • Market Cap

    $125.66 Billion

  • Total Outstanding Shares

    1.47 Billion Shares

  • Total Employees

    48,000

  • Dividend

    No dividend

  • IPO Date

    May 18, 1992

  • SIC Description

    Surgical & Medical Instruments & Apparatus

  • Homepage

    https://www.bostonscientific.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

July 1, 2023 to June 30, 2024
MetricValue
Net Cash Flow From Operating Activities, Continuing$2.63 Billion
Net Cash Flow From Investing Activities, Continuing$-1.81 Billion
Net Cash Flow From Investing Activities$-1.81 Billion
Net Cash Flow$2.44 Billion
Net Cash Flow From Operating Activities$2.63 Billion
Net Cash Flow From Financing Activities$1.62 Billion
Exchange Gains/Losses$-9.00 Million
Net Cash Flow From Financing Activities, Continuing$1.62 Billion
Net Cash Flow, Continuing$2.45 Billion

Income Statement

July 1, 2023 to June 30, 2024
MetricValue
Income/Loss From Continuing Operations After Tax$1.82 Billion
Basic Average Shares$2.94 Billion
Operating Income/Loss$2.47 Billion
Gross Profit$10.50 Billion
Operating Expenses$8.03 Billion
Revenues$15.23 Billion
Preferred Stock Dividends And Other Adjustments$0.00
Income Tax Expense/Benefit$319.00 Million
Net Income/Loss Attributable To Parent$1.83 Billion
Basic Earnings Per Share$1.24
Costs And Expenses$13.09 Billion
Income/Loss From Continuing Operations Before Tax$2.14 Billion
Other Operating Expenses$2.60 Billion
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Cost Of Revenue$4.73 Billion
Interest Expense, Operating$277.00 Million
Net Income/Loss Available To Common Stockholders, Basic$1.83 Billion
Net Income/Loss Attributable To Noncontrolling Interest$-27.00 Million
Benefits Costs and Expenses$13.09 Billion
Net Income/Loss$1.82 Billion
Nonoperating Income/Loss$-329.00 Million
Diluted Earnings Per Share$1.23
Selling, General, and Administrative Expenses$5.43 Billion
Diluted Average Shares$2.96 Billion

Balance Sheet

July 1, 2023 to June 30, 2024
MetricValue
Accounts Payable$906.00 Million
Inventory$2.61 Billion
Equity Attributable To Parent$20.37 Billion
Fixed Assets$2.95 Billion
Equity$20.61 Billion
Assets$37.11 Billion
Other Non-current Assets$19.75 Billion
Liabilities And Equity$37.11 Billion
Intangible Assets$5.42 Billion
Other Current Liabilities$3.72 Billion
Equity Attributable To Noncontrolling Interest$238.00 Million
Liabilities$16.50 Billion
Current Assets$8.99 Billion
Current Liabilities$5.58 Billion
Noncurrent Assets$28.12 Billion
Wages$948.00 Million
Noncurrent Liabilities$10.92 Billion
Other Current Assets$6.38 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
News ArticlesAbout UsPrivacy Policy & Cookies Information

ⓒ2024 Financhle. All Rights Reserved.